Molecular dynamics simulations of the chemokine CCL2 in complex with pull down-derived heparan sulfate hexasaccharides.


Journal

Biochimica et biophysica acta. General subjects
ISSN: 1872-8006
Titre abrégé: Biochim Biophys Acta Gen Subj
Pays: Netherlands
ID NLM: 101731726

Informations de publication

Date de publication:
03 2019
Historique:
received: 16 07 2018
revised: 14 12 2018
accepted: 20 12 2018
pubmed: 27 12 2018
medline: 5 11 2019
entrez: 27 12 2018
Statut: ppublish

Résumé

Binding of chemokines to glycosaminoglycans (GAGs) is a crucial step in leukocyte recruitment to inflamed tissues. A disaccharide compositional analysis of the HS dp6 fraction in combination with MS analysis of the CCL2-depleted dp6 fraction was the basis for target GAG ligand structure suggestions. Four experimentally-derived heparan sulfate hexasaccharides, two potentially chemokine-specific and two unspecific, have been docked to CCL2. Subsequent 300 ns molecular dynamics simulations were used to improve the docked complexes. Hexasaccharides with four sulfations and no acetylations are suggested for selective and high affinity chemokine binding. Using the Antithromin-III/heparin complex as positive control for docking, we were able to recover the correct complex structure only if the previously liganded ATIII structure was used as input. Since the liganded structure is not known for a CCL2-GAG complex, we investigated if molecular dynamics simulations could improve initial docking results. We found that all four GAG oligosaccharides ended up in close contact with the known binding residues after about 100 ns simulation time. A discrimination of specific vs. unspecific CCL2 GAG ligands is not possible by this approach. Long-time molecular dynamics simulations are, however, well suited to capture the delicate enthalpy/entropy balance of GAG binding and improve results obtained from docking. With the comparison of two methods, MS-based ligand identification and molecular modelling, we have shown the current limitations of our molecular understanding of complex ligand binding which is could be due to the numerical inaccessibility of ligand-induced protein conformational changes.

Sections du résumé

BACKGROUND
Binding of chemokines to glycosaminoglycans (GAGs) is a crucial step in leukocyte recruitment to inflamed tissues.
METHODS
A disaccharide compositional analysis of the HS dp6 fraction in combination with MS analysis of the CCL2-depleted dp6 fraction was the basis for target GAG ligand structure suggestions. Four experimentally-derived heparan sulfate hexasaccharides, two potentially chemokine-specific and two unspecific, have been docked to CCL2. Subsequent 300 ns molecular dynamics simulations were used to improve the docked complexes.
RESULTS
Hexasaccharides with four sulfations and no acetylations are suggested for selective and high affinity chemokine binding. Using the Antithromin-III/heparin complex as positive control for docking, we were able to recover the correct complex structure only if the previously liganded ATIII structure was used as input. Since the liganded structure is not known for a CCL2-GAG complex, we investigated if molecular dynamics simulations could improve initial docking results. We found that all four GAG oligosaccharides ended up in close contact with the known binding residues after about 100 ns simulation time.
CONCLUSIONS
A discrimination of specific vs. unspecific CCL2 GAG ligands is not possible by this approach. Long-time molecular dynamics simulations are, however, well suited to capture the delicate enthalpy/entropy balance of GAG binding and improve results obtained from docking.
GENERAL SIGNIFICANCE
With the comparison of two methods, MS-based ligand identification and molecular modelling, we have shown the current limitations of our molecular understanding of complex ligand binding which is could be due to the numerical inaccessibility of ligand-induced protein conformational changes.

Identifiants

pubmed: 30586626
pii: S0304-4165(18)30383-0
doi: 10.1016/j.bbagen.2018.12.014
pii:
doi:

Substances chimiques

Chemokine CCL2 0
Glycosaminoglycans 0
Oligosaccharides 0
Heparitin Sulfate 9050-30-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

528-533

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Sophie Winkler (S)

Institute of Pharmaceutical Sciences, University of Graz, Schubertstraße 1/1, 8010 Graz, Austria.

Rupert Derler (R)

Institute of Pharmaceutical Sciences, University of Graz, Schubertstraße 1/1, 8010 Graz, Austria; Antagonis Biotherapeutics GmbH, Strasserhofweg 77a, 8045 Graz, Austria.

Bernd Gesslbauer (B)

Institute of Pharmaceutical Sciences, University of Graz, Schubertstraße 1/1, 8010 Graz, Austria.

Elmar Krieger (E)

YASARA Biosciences GmbH & CMBI, Wagramer Strasse 25/3/45, 1220 Vienna, Austria.

Andreas J Kungl (AJ)

Institute of Pharmaceutical Sciences, University of Graz, Schubertstraße 1/1, 8010 Graz, Austria; Antagonis Biotherapeutics GmbH, Strasserhofweg 77a, 8045 Graz, Austria. Electronic address: andreas.kungl@uni-graz.at.

Articles similaires

Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
Endometriosis Female Humans Animals Mice

Conservation of the cooling agent binding pocket within the TRPM subfamily.

Kate Huffer, Matthew C S Denley, Elisabeth V Oskoui et al.
1.00
TRPM Cation Channels Animals Binding Sites Mice Pyrimidinones
Fucosyltransferases Drug Repositioning Molecular Docking Simulation Molecular Dynamics Simulation Humans

Classifications MeSH